REDUCTION IN HEPATIC INFLAMMATION IS ASSOCIATED WITH LESS FIBROSIS PROGRESSION AND FEWER CLINICAL OUTCOMES IN ADVANCED HEPATITIS C

OBJECTIVE: During the Hepatitis C Antiviral Long-term Treatment against Cirrhosis Trial, 3.5 years of maintenance peginterferon-alfa-2a therapy did not affect liver fibrosis progression or clinical outcomes among 1,050 prior interferon nonresponders with advanced fibrosis or cirrhosis. We investigat...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Morishima, Chihiro, Shiffman, Mitchell L., Dienstag, Jules L., Lindsay, Karen L, Szabo, Gyongyi, Everson, Gregory T., Lok, Anna S., Di Bisceglie, Adrian M., Ghany, Marc G., Naishadham, Deepa, Morgan, Timothy R., Wright, Elizabeth C.
Format: Artigo
Jezik:Inglês
Izdano: 2012
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3865099/
https://ncbi.nlm.nih.gov/pubmed/22688849
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ajg.2012.137
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items